Cargando…
Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees
BACKGROUND/AIMS: The controlled attenuation parameter (CAP) implemented in FibroScan(®) is reported to be a non-invasive means of detecting steatosis (>10% steatosis). We aimed to evaluate the usefulness of CAP in detecting steatosis among health checkup examinees and to assess its correlation wi...
Autores principales: | Kim, Ja Kyung, Lee, Kwan Sik, Choi, Jung Ran, Chung, Hyun Jung, Jung, Da Hyun, Lee, Kyung Ah, Lee, Jung Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413975/ https://www.ncbi.nlm.nih.gov/pubmed/25717046 http://dx.doi.org/10.5009/gnl14202 |
Ejemplares similares
-
Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
por: Lee, Jung Il, et al.
Publicado: (2019) -
Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022) -
Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
por: Jung, Kyu Sik, et al.
Publicado: (2014) -
Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-based health checkup study
por: Moon, Jae Hoon, et al.
Publicado: (2018) -
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
por: Murayama, Kenichiro, et al.
Publicado: (2021)